Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

Neurology
R S DoodyJ L Cummings

Abstract

To define and investigate key issues in the management of dementia and to make literature-based treatment recommendations. The authors searched the literature for four clinical questions: 1) Does pharmacotherapy for cognitive symptoms improve outcomes in patients with dementia? 2) Does pharmacotherapy for noncognitive symptoms improve outcomes in patients with dementia? 3) Do educational interventions improve outcomes in patients and/or caregivers? 4) Do other nonpharmacologic interventions improve outcomes in patients and/or caregivers? Cholinesterase inhibitors benefit patients with AD (Standard), although the average benefit appears small; vitamin E likely delays the time to clinical worsening (Guideline); selegiline, other antioxidants, anti-inflammatories, and estrogen require further study. Antipsychotics are effective for agitation or psychosis in patients with dementia where environmental manipulation fails (Standard), and antidepressants are effective in depressed patients with dementia (Guideline). Educational programs should be offered to family caregivers to improve caregiver satisfaction and to delay the time to nursing home placement (Guideline). Staff of long-term care facilities should also be educated about AD ...Continue Reading

Citations

Aug 13, 2008·Archives of Neurology·Sid E O'BryantUNKNOWN Texas Alzheimer's Research Consortium
Jun 1, 2005·Tijdschrift voor gerontologie en geriatrie·C J M Schölzel-Dorenbos
Mar 8, 2006·Psychopharmacology·Sebastian WaltherDieter Kunz
May 1, 2008·Psychopharmacology·Lorena R R GianottiUrsula Schreiter-Gasser
Aug 19, 2007·Zeitschrift für Gerontologie und Geriatrie·Manfred GogolHansjörg Werner
Jul 11, 2009·Current HIV/AIDS Reports·Jessica Robinson-PappDavid M Simpson
Aug 14, 2003·Current Neurology and Neuroscience Reports·David A Bennett
Oct 2, 2002·Current Treatment Options in Neurology·Gary J. Tucker, Richard B. Stuart
May 6, 2005·Journal of the American Medical Directors Association·Joseph G OuslanderJohn Schnelle
Oct 26, 2002·Biological Psychiatry·Kenjiro OnoHironobu Naiki
Dec 21, 2002·Neurobiology of Aging·Scott A LynessHelena C Chui
Dec 10, 2002·Neurobiology of Aging·Jason H T Karlawish, Christopher M Clark
Feb 11, 2003·Progress in Neurobiology·J A RibeiroA de Mendonça
Aug 28, 2003·Lancet Neurology·Elio ScarpiniHoward Feldman
Apr 16, 2010·International Journal of Technology Assessment in Health Care·Paulo Dornelles PiconMárcia L F Chaves
Sep 21, 2010·International Psychogeriatrics·Erin R SmithHelen J Chenery
Dec 22, 2012·International Psychogeriatrics·Paula T TrzepaczConstantine Lyketsos
Feb 27, 2009·Journal of the International Neuropsychological Society : JINS·Leslie J Gonzalez RothiStephen E Nadeau
Oct 24, 2006·Nature Clinical Practice. Neurology·Peter V Rabins, Constantine G Lyketsos
Nov 5, 2002·Internal Medicine Journal·D LoGiudice
Jun 18, 2002·Journal of Neurochemistry·Kenjiro OnoHironobu Naiki
Aug 8, 2002·Journal of the American Geriatrics Society·Dina ZekryGabriel Gold
Oct 29, 2004·The New England Journal of Medicine·Jack de la TorreGeorge Perry
Sep 12, 2003·The New England Journal of Medicine·Claudia H Kawas
Apr 15, 2005·The New England Journal of Medicine·Deborah Blacker
Dec 14, 2004·The New England Journal of Medicine·Murat EmreRoger Lane
Apr 15, 2005·The New England Journal of Medicine·Ronald C PetersenUNKNOWN Alzheimer's Disease Cooperative Study Group
Jul 2, 2004·The New England Journal of Medicine·Jeffrey L Cummings
Jul 7, 2007·Aging & Mental Health·Joshua ChodoshLaurence Z Rubenstein
Mar 3, 2009·Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition·Sara Bottiroli, Elena Cavallini
Oct 1, 2013·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Francesca TimpanoPietro Lanzafame
May 14, 2004·Brain : a Journal of Neurology·Andrew J SaykinRobert B Santulli
Dec 19, 2006·Evidence-based Complementary and Alternative Medicine : ECAM·Leopoldo Luiz Dos Santos-NetoGustavo Almeida de Souza
Oct 29, 2008·Evidence-based Complementary and Alternative Medicine : ECAM·Nahid AghabatiZahra Pour Esmaiel
Jul 19, 2008·Epidemiologic Reviews·Jessica J JalbertKate L Lapane
Oct 7, 2003·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Ladislav Volicer, Ann C Hurley
Apr 30, 2005·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·David G BruceFrank Schaper
Dec 17, 2008·The Gerontologist·Joan HydeBrent Forester

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here